The CMC Commercial Asset Development Lead is a member of the Asset Development & Portfolio Management (ADPM) team which provides cross-functional guidance across PO&T’s line functions for commercial assets. The role oversees and owns various aspects of the asset management development, related to asset strategy, development, supply, and life cycle management planning support for the commercial program. This role also represents and provides critical input and considerations to R&D and PDC teams regarding life cycle management activities from the PO&T perspective. This is a high-impact, highly visible leadership role with significant influence on asset value creation and portfolio decisions.
This is a hybrid role that can based in Cambridge, MA or Baar, Switzerland.
You are a seasoned leader with in-depth experience in drug development, supply chain or manufacturing. You will be part of ADPM and lead teams representing PO&T disciplines and maintain critical partnerships with relevant program R&D and/or product commercial leaders. You will be instrumental in leading and facilitating key aspects of the PO&T vision including Influence & Collaborations through engagement with/oversight of collaborations and interface with BD and External Innovation; Data Access and Connectivity by driving best practices for resource management/forecasting decision gates and associated knowledge management initiatives.
This role offers a unique opportunity to:
Job Level: Management
The base compensation range for this role is: $163,000.00-$225,000.00
Base salary offered is determined through an analytical approach utilizing a combination of factors including, but not limited to, relevant skills & experience, job location, and internal equity.
Regular employees are eligible to receive both short term and long-term incentives, including cash bonus and equity incentive opportunities, designed to reward recent achievements and recognize your future potential based on individual, business unit and company performance.
In addition to compensation, Biogen offers a full and highly competitive range of benefits designed to support our employees’ and their families physical, financial, emotional, and social well-being ; including, but not limited to:
We are a global team with a commitment to excellence, and a pioneering spirit. As a mid-sized biotechnology company, we provide the stability and resources of a well-established business while fostering an environment where individual contributions make a significant impact. Our team encompasses some of the most talented and passionate achievers who have unparalleled opportunities for learning, growth, and expanding their skills. Above all, we work together to deliver life-changing medicines, with every role playing a vital part in our mission. Caring Deeply. Achieving Excellence. Changing Lives.
At Biogen, we are committed to building on our culture of inclusion and belonging that reflects the communities where we operate and the patients we serve. We know that diverse backgrounds, cultures, and perspectives make us a stronger and more innovative company, and we are focused on building teams where every employee feels empowered and inspired. [Read on](https://nam12.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.biogen.com%2Fresponsibility%2Fdiversity-inclusion.html&data=05%7C01%7Cdennis.mercier%40biogen.com%7C67adaf5a6edd4324716208db0dcd2182%7C7b7466bbfe1d47a0b9438ded565c8e54%7C0%7C0%7C638118946897044815%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=p2vFGx6ZWK7lyBEL4wuNIQJcKSVRZD90VuJxcOkjX04%3D&reserved=0) to learn more about Biogen.
All qualified applicants will receive consideration for employment without regard to sex, gender identity or expression, sexual orientation, marital status, race, color, national origin, ancestry, ethnicity, religion, age, veteran status, disability, genetic information or any other basis protected by federal, state or local law. Biogen is an E-Verify Employer in the United States.
Biogen is a leading biotech company focused on neurological diseases, developing innovative medicines, biologics, small molecules, and biosimilars.
View company profile →